Inserm Research Director
NODS-like Receptors in Infection and Immunity team leader
Unit 1019 Center for Infection and Immunity of Lille (CIIL)
+33 (0)3 59 31 74 27
A mechanism of tolerance towards intestinal flora is thought to be implicated in the onset of a rare familial autoinflammatory disease induced by cold temperatures. This is the finding of researchers from the Center for Infection and Immunity of Lille (Inserm/Université de Lille/CNRS/University Hospital Lille/Institut Pasteur de Lille), the Pathophysiology of Pediatric Genetic Diseases laboratory (Inserm/Sorbonne Université) and the Department of Immunology at the University of Hohenheim. Their research, published in Nature Communications, reveals the implication in its onset of an exacerbated inflammatory response against the gut flora, making for a more effective immune response against certain pathogens. Findings which open up new avenues when it comes to treating patients.
Familial cold autoinflammatory syndrome (or familial cold urticaria) is characterized by episodes of fever triggered by cold temperatures, accompanied by hives and gastrointestinal and joint pain. The patients – with some twenty cases identified to date – carry an NLRP12 gene mutation that is inherited in an autosomal dominant manner (the presence of a single mutated allele is enough to bring on the disease). Until now, the pathophysiological mechanisms behind the disease were unknown.
A team led by Mathias Chamaillard, Inserm researcher at the Center for Infection and Immunity of Lille (Inserm/Université de Lille/CNRS/University Hospital Lille/Institut Pasteur de Lille) along with his coworkers at the Pathophysiology of Pediatric Genetic Diseases laboratory (Inserm/Sorbonne Université) and Department of Immunology at the University of Hohenheim, sought to elucidate the development of this syndrome through human and mouse studies.
The researchers saw that while inactivating the NLRP12 gene in mice triggered inflammation in the gut, it made it resistant to certain pathogenic bacteria, suggesting that NLRP12 could play a key role in immune tolerance towards intestinal flora.
However, they observed that another molecule, NOD2, also played a role in intestinal immunity by promoting the defense against these same bacterial pathogens.
Reduced tolerance of intestinal flora bacteria
In individuals with familial cold autoinflammatory syndrome, the production of protein NLRP12 is reduced. When reproduced in mice, this phenomenon modifies NOD2 activity and reduces tolerance of commensal bacteria with an intensified recruitment of inflammatory cells in the digestive tract. However, the efficacy of pathogen elimination is improved. In other words, under normal conditions, NLRP12 suppresses NOD2 activity and improves tolerance of intestinal bacteria. These findings suggest that an inhibitor of the NOD2 pathway could attenuate these patients’ symptoms.
For a deeper insight into the social and epidemiological challenges posed by the exceptional prevention measures taken in response to the COVID-19 pandemic – particularly confinement – a multidisciplinary group of researchers has joined forces with Inserm and the Public Health Agency ...
The teams of the Infectious and Tropical Diseases Hospital Bichat AP-HP and the University Hospital of Bordeaux, in collaboration with researchers from University of Paris, Inserm IAME UMRS-1137 (University of Paris / INSERM / University Sorbonne Paris Nord), the Institut Pasteur, the ...
Proteasomal degradation of NOD2 by NLRP12 in monocytes promotes bacterial tolerance and colonization by enteropathogens
Sylvain Normand1, Nadine Waldschmitt1,2, Andreas Neerincx3, Julio Martinez-Torres4, Camille Chauvin1, Aurélie Couturier-Maillard1, Olivier Boulard1, Laetitia Cobret5,6, Fawaz Awad5,6, Ludovic Huot1, Andre Ribeiro-Ribeiro4, Katja Lautz7, Richard Ruez1, Myriam Delacre1, Clovis Bondu1, Martin Guilliams8,9, Charlotte Scott8,9, Anthony Segal4, Serge Amselem5,6, David Hot1, Sonia Karabina5,6, Erwin Bohn10, Bernhard Ryffel11, Lionel F. Poulin1, Thomas A. Kufer 12 & Mathias Chamaillard1
1 University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d′Infection et d′Immunité de Lille, F-59000 Lille, France.
2 Technische Universität München, Chair of Nutrition and Immunology, 85350 Freising-Weihenstephan, Germany.
3 Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK.
4 Division of Medicine, University College London, WC1E 6BT London, UK.
5 Sorbonne Universités, UPMC Univ Paris 06, UMR_S 933, F-75012 Paris, France.
6 Inserm, UMR_S 933, F-75012 Paris, France.
7 Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany.
8 Laboratory of Immunoregulation, VIB Inflammation Research Center, 9052 Ghent, Belgium.
9 Department of Internal Medicine, Ghent University, Ghent 9000, Belgium.
10 Interfakultaeres Institut für Mikrobiologie und Infektionsmedizin, Eberhard Karl Universitat Tuebingen, 72076 Tuebingen, Germany.
11 CNRS, Orléans University, INEM, UMR 7355, F-45071 Orléans, France.
12 Department of Immunology, Institute of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany.
Nature Communications : https://doi.org/10.1038/s41467-018-07750-5